Re: FDG PET/CT Findings of Intracardiac Myeloid Sarcoma

Clin Nucl Med. 2017 Mar;42(3):242-245. doi: 10.1097/RLU.0000000000001425.

Authors

Kamal Kant Sahu¹, Archana Gautam, Sikander Ailawadhi

Affiliation

¹ Division of Hematology/Oncology, Department of Internal Medicine, Postgraduate Institute of Medical Education, and Research (PGIMER), Chandigarh, India, everlastingkamal@yahoo.com, †Department of Internal Medicine, University College ofMedical Sciences (UCMS), New Delhi, India, ‡Division of Hematology/Oncology, Department of Medicine, Mayo Clinic, Jacksonville, FL.

PMID: 27819854
DOI: 10.1097/RLU.0000000000001425

No abstract available

Publication types

Letter
Comment

MeSH terms

Fluorodeoxyglucose F18
Humans
Positron Emission Tomography Computed Tomography*
Positron-Emission Tomography
Radiopharmaceuticals
Sarcoma
Sarcoma, Myeloid*
Tomography, X-Ray Computed

Substances

Radiopharmaceuticals
Fluorodeoxyglucose F18